SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-159256
Filing Date
2018-05-10
Accepted
2018-05-10 16:23:25
Documents
61
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d573032d10q.htm 10-Q 436656
2 EX-31.1 d573032dex311.htm EX-31.1 6448
3 EX-31.2 d573032dex312.htm EX-31.2 6448
4 EX-32.1 d573032dex321.htm EX-32.1 4517
5 EX-32.2 d573032dex322.htm EX-32.2 4416
  Complete submission text file 0001193125-18-159256.txt   2605296

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT elox-20180331.xml EX-101.INS 359666
7 XBRL TAXONOMY EXTENSION SCHEMA elox-20180331.xsd EX-101.SCH 39638
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE elox-20180331_cal.xml EX-101.CAL 40660
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elox-20180331_def.xml EX-101.DEF 139046
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE elox-20180331_lab.xml EX-101.LAB 280419
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elox-20180331_pre.xml EX-101.PRE 220292
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31326 | Film No.: 18822857
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services